Background: The diffusion of novel psychoactive substances (NPSs), combined with the
| INTRODUCTION
Over the last decade, the diffusion of new recreational drug trends involving novel psychoactive substances (NPSs), also misleadingly known as "herbal highs", or "smart drugs" (Corazza, Demetrovics, van den Brink, & Schifano, 2013) , has emerged as a prominent issue for the fields of drug policy, research, and public health (EMCDDA, 2015; Schifano, Orsolini, Duccio Papanti, & Corkery, 2015) . The galaxy of NPSs is very complex, and it includes a range of very different molecules such as phenethylamines and novel stimulants, synthetic cannabinoids, cathinone derivatives, synthetic opiates or opioids, tryptamine derivatives, phencyclidine-like dissociatives, piperazines, GABA-A or GABA-B receptor agonists, certain medications, psychoactive plants or herbs, and the so-called "performance and image-enhancing drugs" Corazza et al., 2014; Gray, Bressington, Hughes, & Ivanecka, 2016; Schifano et al., 2015) .
Both the growing number of NPSs and the rapidity with which they appear on the illicit drug market have led to unprecedented challenges for government organisations, health agencies, and substance misuse services Cinosi et al., 2015; Gray et al., 2016) . Moreover, these new products, often marketed as alternatives to other more common illicit drugs, are becoming increasingly available (Bersani, Imperatori, Prilutskaya, Kuliev, & Corazza, 2015; Gray et al., 2016; Valeriani et al., 2015) . With the Internet acting as an online marketplace, NPSs are often sold as "mystical incenses," "plant chemicals," and "bath salts" (Bersani et al., 2016; Gray et al., 2016; Meyer, 2016) . They are often sold at discounted prices and easy to purchase and are perceived as "safer" than classic psychoactives. Nevertheless, NPSs can represent a serious threat for both physical and mental health (Santacroce et al., 2015) .
NPSs are often unknown to health professionals, as they are not properly documented in scientific literature Meyer, 2016) ; it is thus becoming clear that reliable and easily accessible information on the topic is necessary, especially among health and other professionals (e.g., police and social workers) working in the field.
Mobile phones are nowadays one of the easiest ways to communicate. Interventions based on short message service (SMS) and smartphone-based technology (i.e., the so-called "apps") have been extensively used in health research in the fields of mental health, addiction, weight loss or management, parenting, sexual health, diabetes, oncology, and human immunodeficiency virus (Anthes, 2016; Bigelow, Carta, & Lefever, 2008; Brendryen, Drozd, & Kraft, 2008; Fjeldsoe, Miller, & Marshall, 2010; Gerber, Stolley, Thompson, Sharp, & Fitzgibbon, 2009; Kim & Kim, 2008; Kypri & Lee, 2009; Nasi, Cucciniello, & Guerrazzi, 2015; Whittaker, Mc Robbie, Bullen, Rodgers, & Gu, 2016; Ybarra & Bull, 2007) . Overall, it is recognized that health-related mobile tools can have a crucial role to play, because they can improve communication and enhance the integration of care processes.
In this context, the first mobile app on NPSs, SMAIL (an acronym that combines "Sms" and "eMAIL"), was launched in May 2012 as a result of the EU-funded "ReDNet project" (Corazza, Assi, & Simonato, 2013) to help health and other professionals to keep up-to-date and receive a rapid response on their enquires on NPSs, especially in absence of relevant information on Medline or other scientific databases.
| METHODS
The development of SMAIL was divided into two parts: (a) the creation of the application for registered users, enabling them to send an SMS or email with the name or "street name" of an NPS and receive within seconds emails or SMS with the information on the nature and the risks of the drug, when available and (b) the development of a database to support the incoming requests linked with technical factsheets created by the researchers. Ethical approval for this study was granted by the School of Pharmacy Ethics Committee, University of Hertfordshire, Hatfield, United Kingdom (November 2013; PHAEC/10-42).
To promote the pilot research, a snowball sampling was used (i.e., an invitation to join SMAIL was disseminated among researchers working in the field, while encouraging them to further disseminate it among their acquaintances). Registrations to the SMAIL service occurred online via a dedicated website. Registered users could use a mobile device, or an email address, to send the name or the street name (e.g., "Pink Panther" and "Black Mamba") of a specific NPS to the system, which was available on a 24/7 basis. If the drug name matched with the stored list of drug names in the SMAIL database, information about the drug was automatically sent back to the mobile phone or to the email address within 10 s. If the name was misspelled by the user (e.g., "Canfeamine" rather than "Camfetamine"), the system suggested the plausible correct name and sent the relevant information. If the system was not able to find a matched name in the database, the user received an SMS or email declining the request of information.
The SMAIL database included factsheets on 57 NPSs known by the researchers at the time of this pilot study (i.e., from May 2012 to September 2013). These included groups of new phenethylamines, tryptamines, piperazines, synthetic cannabinoids and cathinones, ketamine-like compounds, and plant-based substances. Information on NPSs emerged from multilingual reviews of the available peerreviewed literature, as well as from nonconventional, fugitive, and ephemeral publications (also known as "grey literature"; Alberani, De Castro Pietrangeli, & Mazza, 1990) , which consisted in government reports, preliminary documents, technical documentations, and anecdotal reports from media or the Internet. Information sheets included key points about each substance, such as legal status, diffusion, chemical characteristics, and pharmacological or toxicological effects. The content was presented in a friendly "question and answer" format with thumbnail photos. During the study period, the developers of the app had regular access to the tool and kept constantly updated the information on the substances.
| RESULTS
Overall, 122 users registered to SMAIL internationally, 52% males and 48% females, with an average age of 36.96 ± 9.3 years. SMAIL users were mostly health professionals (37%), workers in the drug or addiction field (25%), and researchers (24%). Five hundred fifty-seven searches have been performed until September 2013, mainly via SMS (94.6%) and from smartphone devices. Full details on the research outcomes are illustrated in Table 1 .
Although registered health professionals were from 22 different countries, the searches were mainly performed from six countries and mostly from the UK (78.6%). The most searched substances were mephedrone (53.7%), methylenedioxypyrovalerone (4.8%), substituted benzofurans (6APB; 4.7%), 5,6-methylenedioxy-2-aminoindane (4.3%), and methoxetamine (3.8%).
Despite the fact that the database included the majority of the NPSs discussed in scientific papers, regulatory reports, and media sources, SMAIL was not able to capture 53.7% of requests. This was mainly due to four reasons: (a) searched products were unknown to the researchers and therefore were not contained in the database (47.5%); for example, users searched for "doob," "ocean snow," and "TMA6" nicknames, which were not mentioned in any scientific, governmental, or media-related source; (b) health care professionals searched for "classic" drugs (12.4%) such as "cocaine," "heroin," "3,4-methylenedioxymethamphetamine (MDMA)," "methadone," or "ecstasy" (12.4%), which were not included in the SMAIL database; Our results also suggested that registered users, mainly health professionals, were not familiar with the definition of NPSs, as they often asked information on classic, rather than "novel," compounds.
Such poor level of knowledge on NPSs also emerged from previous studies in the field. Fifty-seven percent of health professionals in the UK seeing patients with NPS-related problems rated their level of knowledge in the field as "poor" or "basic" .
Similarly, in Italy, one out of four health professionals did not even know if their patients were using NPSs . Given the high impact on physical and mental health, the misuse of NPSs should be regularly included in the patients' anamnesis, and health care professionals should be able to identify rapidly these compounds in order to avoid errors in the assessment phase.
Major limitations of this pilot study include (a) the use of the tool by a small (n = 122) number of users, mainly from Italy and the UK, thus our findings lack a broader international dimension and should be further validated in larger cohorts; (b) its observational nature, which requires future studies inclusive of more specific efficacy endpoints;
and (c) a large number (more than half) of unmet requests from users, which required constant updates of the attached database, which can be challenging especially in light of the speed at which NPSs appear on the illicit drug market and the availability of limited resources. Note. GBL = γ-Butyrolactone; γ-hydroxybutyrate; MDAI = 5,6-methylenedioxy-2-aminoindane; NPS = novel psychoactive substance; SMS = short message service; MDPV = methylenedioxypyrovalerone.
